Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Reducing Respone Time Letter - Evarrest


Our STN: BL 125392/0
Ethicon Inc
Attention: Ms. Jessica Chung
G-106-10, P.O. Box 151
Route 22 West
Somerville, NJ  08876-0151
Dear Ms. Chung:
We have received your October 5, 2012 resubmission to your biologics license application for Fibrin Sealant Patch on October 9, 2012.
The resubmission contains a revised draft Prescribing Information and Package Label that you submitted in response to our September 28, 2012 complete response letter. 
We consider this a complete, class 1 response to our action letter. Therefore, the user fee goal date is December 9, 2012.
If you have any questions, please contact the Regulatory Project Manager, Tracy Tilghman, at (301) 827-9427.
Sincerely yours,
Iliana Valencia, M.S.
Chief, Regulatory Project
Management Branch
Division of Blood Applications
Office of Blood Research and Review
Center for Biologics
 Evaluation and Research

Page Last Updated: 01/18/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English